fcn-437c
Small moleculeexperimental
Clinical trial activity
6 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started Feb 14, 2019 (NCT04488107)
Timeline
Indications
Mechanism of action
- Cyclin-dependent kinase 6INHIBITOR
CDK6 inhibitor
- Cyclin-dependent kinase 4INHIBITOR
CDK4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06620731 | Phase 1 | Sep 4, 2023 | Fosun, Jinlin University |
| NCT05439499 | Phase 3 | Mar 2, 2022 | Chinese Academy of Medical Sciences, Fosun |
| NCT05438810 | Phase 3 | Jan 18, 2022 | Fosun, Fudan University |
| NCT05004142 | Phase 2 | Jun 30, 2020 | Fosun, Hebei University, Jinlin University |
| NCT03951116 | Phase 1 | May 24, 2019 | Fochon Pharmaceuticals, Ltd., South Texas Accelerated Research Therapeutics |
| NCT04488107 | Phase 1/Phase 2 (Phase 2) | Feb 14, 2019 | Chinese Academy of Medical Sciences, Fosun, Fudan University, Zhejiang University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fosun | For profit | 5 | 5 | 3 | 2019 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 2 | 2019 |
| Fudan University | Academic/Hospital | 2 | 0 | 2 | 2019 |
| Jinlin University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Fochon Pharmaceuticals, Ltd. | For profit | 1 | 1 | 1 | 2019 |
| Hebei University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| South Texas Accelerated Research Therapeutics | For profit | 1 | 0 | 1 | 2019 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2019 |
8 organizations
Page 1 / 1